TY  - BOOK
AU  - Flanigan,Jessica
TI  - Pharmaceutical freedom: why patients have a right to self medicate 
SN  - 9780190684570
AV  - RA401.A1 
U1  - 362.1782 23
PY  - 2017///]
CY  - New York
PB  - Oxford University Press
KW  - Drug accessibility
KW  - Law and legislation
KW  - Pharmacy
KW  - Medical laws and legislation
KW  - Self medication
KW  - Ethics, Clinical
KW  - Self Medication
KW  - Prescription Drugs
KW  - Paternalism
KW  - Drug Industry
KW  - ethics
KW  - Patient Rights
KW  - Self Administration
KW  - Automédication
KW  - POLITICAL SCIENCE
KW  - Public Policy
KW  - Social Security
KW  - bisacsh
KW  - Social Services & Welfare
KW  - fast
KW  - Electronic books
N1  - Includes bibliographical references and index; Cover; Pharmaceutical Freedom; Copyright; Contents; Acknowledgments; Introduction; 1. A Defense of Self-​Medication; 1.1 Two Motivating Cases; 1.2 Patients Know Best; 1.3 Patient Expertise and Drug Choice; 1.4 Intimate Choices; 1.5 Anti-​paternalism and Freedom to Choose; 1.6 Patient Protection; 1.7 Ignorance and Fraud; 1.8 Self-​Medication and Unapproved Drugs; 1.9 Self-​Medication and Prescription Drugs; 1.10 Conclusion; 2. Paternalism and Public Health; 2.1 Prohibition and Protection; 2.2 Soft Paternalism and Drug Regulation; 2.3 Children and Incompetent Adults; 2.4 Hard Paternalism and Drug Regulation2.5 The Health Effects of Approval Requirements; 2.6 The Health Effects of Prescription Policies; 2.7 The Regulatory Reversal Test; 2.8 Certification Versus Approval; 2.9 Conclusion; 3. Rethinking Prescription Requirements; 3.1 Deadly Drugs; 3.2 Recreational Drugs and Addiction; 3.3 Therapeutics; 3.4 Antibiotics; 3.5 The Case for OTC Enhancements; 3.6 Rethinking Non-​Medical Use; 3.7 Public Health and Preventive Medication; 3.8 Conclusion; 4. Responsibility and Regulation; 4.1 How Regulation Kills; 4.2 Necessity and the Need to Test; 4.3 Non-​Ideal and Ideal Theory4.4 The Risks of an Approval System; 4.5 The Risks of a Certification System; 4.6 Conclusion; 5. The Politics of Self-​Medication; 5.1 Patient-​Driven Development; 5.2 Disobedience and Distribution; 5.3 Civil Disobedience; 5.4 Protest and Activism; 5.5 Democratic Authority and Self-​Medication; 5.6 Conclusion; 6. The Business of Medicine; 6.1 Single Standards for Industry; 6.2 Private Options and the Global Marketplace; 6.3 Drug Prices and Deregulation; 6.4 Lifesaving Innovation and Patents; 6.5 Patents and Prizes; 6.6 Patents and the Rights of Producers; 6.7 Conclusion7. Medical Autonomy and Modern Healthcare; 7.1 Markets and Medical Autonomy; 7.2 Pharmaceutical Marketing; 7.3 Off-​Label Marketing; 7.4 Professional Ethics; 7.5 Torts and Product Liability; 7.6 Insurance and Social Costs; 7.7 Conclusion; 8. Conclusion; References; Index
N2  - Jessica Flanigan defends patients' rights of self-medication on the grounds that same moral reasons against medical paternalism in clinical contexts are also reasons against paternalistic pharmaceutical policies, including prohibitive approval processes and prescription requirements
UR  - https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1540220
ER  -